IL-6 UPREGULATES ITS OWN RECEPTOR ON SOME HUMAN MYELOMA CELL LINES
- 30 June 2001
- journal article
- research article
- Published by Elsevier BV in Cytokine
- Vol. 14 (6), 352-356
- https://doi.org/10.1006/cyto.2001.0911
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma CellsImmunity, 1999
- IFN-α Is a Survival Factor for Human Myeloma Cells and Reduces Dexamethasone-Induced ApoptosisThe Journal of Immunology, 1998
- Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathwayBiochemical Journal, 1998
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996
- IL-6 cytokine family and signal transduction: a model of the cytokine systemJournal of Molecular Medicine, 1996
- Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell linesEuropean Journal of Immunology, 1994
- The IL-6 Signal Transducer, gp130: an Pncostatin M Receptor and Affinity Converter for the LIF ReceptorScience, 1992
- Studies on the structure and regulation of the human hepatic interleukin‐6 receptorEuropean Journal of Biochemistry, 1990
- Regulation of interleukin‐6 receptor expression in human monocytes and hepatocytesFEBS Letters, 1989
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988